Integra LifeSciences Holdings Corporation
IART
$9.55
-$0.02-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7,337.70% | -7,468.14% | -2,217.00% | -171.97% | -110.25% |
| Total Depreciation and Amortization | 7.76% | 24.30% | 27.71% | 19.99% | 14.07% |
| Total Amortization of Deferred Charges | 0.21% | 6.47% | 5.29% | -1.62% | -9.26% |
| Total Other Non-Cash Items | 2,025.76% | 2,149.17% | 1,149.37% | -54.23% | -13.54% |
| Change in Net Operating Assets | -8.80% | -240.26% | -10.56% | 48.15% | 61.99% |
| Cash from Operations | -61.06% | -35.00% | -49.97% | -20.98% | -7.55% |
| Capital Expenditure | 22.01% | 5.57% | -30.84% | -71.76% | -56.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 101.48% | 101.48% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -210.37% | 119.59% | 141.82% | 134.83% | 68.59% |
| Cash from Investing | 72.35% | 82.56% | 83.63% | -177.27% | -314.97% |
| Total Debt Issued | 48.14% | 50.52% | -78.50% | -67.57% | 194.67% |
| Total Debt Repaid | -257.98% | -298.37% | 39.82% | -65.29% | -69.20% |
| Issuance of Common Stock | -85.04% | -85.55% | -86.85% | -88.59% | 48.20% |
| Repurchase of Common Stock | 94.79% | 89.96% | 97.00% | 57.29% | 80.07% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -72.06% | -66.73% | -66.12% | -4,724.92% | -51.33% |
| Cash from Financing | -88.09% | -101.33% | -106.16% | -129.32% | 203.45% |
| Foreign Exchange rate Adjustments | 378.73% | -14.59% | 675.81% | 250.57% | -266.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.28% | 129.07% | 102.85% | -223.99% | 83.34% |